Enhanc3D Genomics

About:

Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.

Website: https://enhanc3dgenomics.com/

Top Investors: Business Growth Fund, Parkwalk Advisors, Bioqube Ventures, Johnson & Johnson Robotics and Digital Solutions, Start Codon

Description:

Enhanc3D Genomics is a functional genomics firm that studies the three-dimensional organization of DNA in health and disease. The company's GenLink3D platform helps comprehend the impact of such mutations on distant genes, thereby revealing how they influence disease progression.

Total Funding Amount:

10M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2020-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-10-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai